Highly expressed 4EBP1 was associated to worse prognosis of overall survival (OS) among the 10 of 33 cancer types (Figure 2; Supplementary Figure S2), including ACC (p = 0.002; HR = 3.7), BLCA (p = 0.017; HR = 1.4), BRCA (p = 0.024; HR = 1.5), KIRC (p = 4.1e-05; HR = 1.9), KIRP (p = 0.018; HR = 2.2), LAML (p = 0.039; HR = 1.8), MESO (p = 3.6e-05; HR = 2.9), SARC (p = 0.0053; HR = 1.8), SKCM (p = 0.032; HR = 1.3), and UCES (p = 0.038; HR = 2.2) within the TCGA project (Supplementary Figures S2B–K). Here, EIF4EBP1 is linked to cancer.